Use of tramadol in early pregnancy and congenital malformation risk

Reproductive Toxicology

Volumn 58, Issue , 2015, Pages 246-251

  Källén, Bengt ^a   Reis, Margareta ^b,c  

^a UNIVERSITY OF LUND   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiovascular defects; Congenital malformations; Opioids; Pes equinovarus; Tramadol

Indexed keywords

ANALGESIC AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIGASTROESOPHAGEAL REFLUX AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIMIGRAINE AGENT; CODEINE; CONTRACEPTIVE AGENT; CORTICOSTEROID; DEXTROPROPOXYPHENE; FENTANYL; FERTILITY PROMOTING AGENT; GESTAGEN; HYDROMORPHONE; HYPNOTIC AGENT; KETOBEMIDONE; MORPHINE; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXYCODONE; PARACETAMOL; PENTAZOCINE; PETHIDINE; SEDATIVE AGENT; TRAMADOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; NARCOTIC ANALGESIC AGENT; TERATOGENIC AGENT;

ADULT; AGE; ANKYLOGLOSSIA; AORTA COARCTATION; AORTA VALVE STENOSIS; ARTICLE; CARDIOVASCULAR DISEASE; CLEFT LIP; CLEFT PALATE; COMBINATION CHEMOTHERAPY; CONGENITAL MALFORMATION; CONTROLLED STUDY; CRANIOFACIAL SYNOSTOSIS; CRYPTORCHISM; DELIVERY; DIAPHRAGM HERNIA; DISEASE REGISTRY; DISEASE SEVERITY; DOWN SYNDROME; DRUG EXPOSURE; EAR MALFORMATION; ENDOCARDIAL CUSHION DEFECT; ESOPHAGUS ATRESIA; FEMALE; FIBULAR LONGITUDINAL REDUCTION DEFORMITY; FIRST TRIMESTER PREGNANCY; FOOT DISEASE; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HIGH RISK PREGNANCY; HIP DISEASE; HIP DISLOCATION; HUMAN; HYDRONEPHROSIS; HYPOSPADIAS; INFANT; INNER EAR MALFORMATION; IRIS COLOBOMA; ISOLATED CARDIOVASCULAR DEFECT; KIDNEY DYSPLASIA; KNEE DISEASE; MAJOR CLINICAL STUDY; MICROPHTHALMIA; MIDDLE AGED; MONOTHERAPY; NEUROFIBROMATOSIS; NEVUS; OCCIPITAL ENCEPHALOCELE; PARITY; PATENT DUCTUS ARTERIOSUS; PES EQUINOVARUS; POLYDACTYLY; PREAURICULAR TAG; PULMONARY ARTERY STENOSIS; PULMONARY VALVE STENOSIS; PYLORUS STENOSIS; SPINAL DYSRAPHISM; STRUCTURED INTERVIEW; SWEDISH CITIZEN; TERATOGENICITY; TRACHEOMALACIA; TRUNCUS COMMUNIS; VESICOURETERAL REFLUX; YOUNG ADULT; ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; GESTATIONAL AGE; ODDS RATIO; PREGNANCY; REGISTER; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SWEDEN;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; ANALGESICS, OPIOID; FEMALE; GESTATIONAL AGE; HUMANS; ODDS RATIO; PREGNANCY; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SWEDEN; TERATOGENS; TRAMADOL; YOUNG ADULT;

EID: 84946724086     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2015.10.007     Document Type: Article

References (19)

1. Abdel-Latif M.E., Oei J., Craig F., Lui K.N.S.W., ACTNAS Epidemiology Group Profile of infants born to drug-using mothers: a state-wide audit. J. Paediatr. Child Health 2013, 49:E80-E86. 10.1111/j.1440-1754.2012.02471x.
2. Wendell A.D. Overview and epidemiology of substance abuse in pregnancy. Clin. Obstet. Gynecol. 2013, 56:91-96.
3. Osborn D.A., Jeffery H.E., Cole M. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst. Rev. 2005, 10.1002/14651858.
4. Walhovd K.B., Moe V., Slinning K., Sigeland T., Fjell A.M., Bjørnebekk A.B., Smith L. Effects of prenatal opiate exposure on brain development -a call for attention. Nat. Rev. Neurosci. 2009, 10:390.
5. Thompson B.L., Levitt P., Stanwood G.D. Perinatal exposure to drugs: effects on brain development and implications for policy and education. Nat. Rev. Neurosci. 2009, 10:303-312.
6. Broussard C.S., Rasmusson S.A., Reefhuis J., Friedman J.M., Jann M.W., Riehle-Colarusso T., Honein M.A. Maternal treatment with opioid analgesics and risk for bith defects. Am. J. Obstet. Gynecol. 2011, 204(314):e1-11. 10.1016/j.ajog.2010.12.39.
7. Nezvalova-Henriksen K., Spigset O., Nordeng H. Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur. J. Clin. Pharmacol. 2011, 67:1243-1261.
8. Grond S., Sablotzki A. Clinical phamacology of tramadol. Clin. Pharmacokinet. 2004, 43:879-923.
9. Bloor M., Paech M.J., Kaye R. Tramadol in pregnancy and lactation. Int. J. Obstet. Anesth. 2012, 21:163-167.
10. Gouraud A., Carlier P., Thompson M.A., Garayt C., Bernard N., Vial T. First trimester exposure to tramadol: a prospective comparative study. Fundam. Clin. Pharmacol. 2010, 24:90. Abstract No . 435.
11. National Board of Health and Welfare (2012). Läkemedel-statistik för 2012. (Pharmaceuticals -statistics for 2012). (In Swedish). http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19023/2012-3-21.pdf.
12. Källén B., Otterblad Olausson P. Monitoring of maternal drug use and infant congenital malformations. Does loratadine cause hypospadias. Int. J. Risk Saf. Med. 2001, 14:115-119.
13. Yazdy M.M., Mitchell A.A., Tinker S.C., Parker S.E., Werler M.M. Periconceptional use of opioids and the risk of neural tube defects. Obstet. Gynecol. 2012, 122:838-844.
14. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J. Pharmacol. Exp. Ther. 1992, 260:275-285.
15. Raffa R.B., Friderichs E., Reimann W., Shank R.P., Codd E.E., Vaught J.L., Jacoby H.I., Selve N. Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J. Pharmacol. Exp. Ther. 1998, 267:331-340.
16. Paar W.D., Frankus P., Dengler H.J. The metabolism of tramadol by human liver microsomes. Clin. Invest. 1992, 70:708-710.
17. Subrahmanyam V., Renwick A.B., Walters D.G., Young P.J., Price R.J., Tonelli A.-P., Lake B.G. Identification of cytochrome P-450 isoforms responsible for cis-tramadol metabolism in human liver microsomes. Drug Metab. Dispos. 2001, 29:1146-1155.
18. Markowitz J.S., Patrick K.S. Venlafaxine-tramadol similarities. Med. Hypotheses 1993, 51:167-168.
19. Reis M., Källén B. Delivery outcome after maternal use of antidepressant drugs in pregnancy. An update using Swedish data. Psychol. Med. 2010, 40:1723-1733.